Insight Molecular Diagnostics Inc.

IMDX Nasdaq SEC CIK 1642380
Follow Insight Molecular Diagnostics Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $559K +115% vs same quarter last year
Net income −$3.6M +67% vs same quarter last year
EPS, diluted −$0.10 +70.6% vs same quarter last year
Operating cash flow −$6.4M −39.1% vs same quarter last year
Revenue by quarter
$1.5M
$2.1M
$518K
$260K
$1.1M
$32K
$239K
$559K
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income13 fiscal years
  • Revenue
  • Net income
−$80M−$60M−$40M−$20M$0$20MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$4.1M−$50.2K
FY24$1.9M−$60.7K
FY23$1.5M−$27.8K
FY22$958K−$72.9M
FY21$2.2M−$64.1M
FY20$1.2M−$29.9M
FY19-−$22.4M
FY18-−$15.8M
FY17-−$19.4M
FY16-−$11.2M
FY15$0−$8.7M
FY14-−$5M
FY13--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−8000%−6000%−4000%−2000%0%2000%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2556.7%−1260.8%−1.2%
FY2439.3%−3245.1%−3.2%
FY2327.5%−1672.4%−1.8%
FY22−1.9%−1878.6%−7609.8%
FY2164.6%−2444.3%−2916.2%
FY20−52.5%−2443.3%−2461.5%
FY19---
FY18---
FY17---
FY16---
FY15---
FY14---
FY13---
Free cash flowOperating cash flow minus capital expenditure
−$60M−$40M−$20M$0FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$25.4M
FY24−$21.2M
FY23−$23.6M
FY22−$49.9M
FY21−$38.2M
FY20−$27.2M
FY19−$20.6M
FY18−$11.7M
FY17−$13.5M
FY16−$7.6M
FY15−$4.7M
FY14−$1.2M
FY13-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Insight Molecular Diagnostics
  • Healthcare median
−8000%−6000%−4000%−2000%0%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearInsight Molecular DiagnosticsHealthcare median
FY25−1.2%−30.6%
FY24−3.2%−47%
FY23−1.8%−58%
FY22−7609.8%−80.4%
FY21−2916.2%−71.9%
FY20−2461.5%−62.2%
FY19-−46.3%
FY18-−49.6%
FY17-−45.9%
FY16-−36%
FY15-−38.4%
FY14-−35.5%
FY13-−37.1%